Jallal Bahija - 02 Jan 2024 Form 3 Insider Report for Immunocore Holdings plc (IMCR)

Role
Chief Executive Officer, Director
Signature
/s/ Bahija Jallal
Issuer symbol
IMCR
Transactions as of
02 Jan 2024
Net transactions value
$0
Form type
3
Filing time
02 Jan 2024, 16:51:10 UTC
Previous filing
12 May 2023
Next filing
29 Jan 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding IMCR Employee Share Option (Right to Buy) 02 Jan 2024 Ordinary Shares 1,854,470 $17.46 Direct F1
holding IMCR Employee Share Option (Right to Buy) 02 Jan 2024 Ordinary Shares 28,345 $17.46 Direct F2
holding IMCR Employee Share Option (Right to Buy) 02 Jan 2024 Ordinary Shares 2,076,080 $26.00 Direct F3
holding IMCR Employee Share Option (Right to Buy) 02 Jan 2024 Ordinary Shares 445,577 $24.66 Direct F4
holding IMCR Employee Share Option (Right to Buy) 02 Jan 2024 Ordinary Shares 259,214 $64.53 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The original option award was for 2,079,470 shares. 25% of the shares subject to the option award vested on January 7, 2021, and 6.25% of the shares subject to the option award vested or shall vest in quarterly installments thereafter, subject to the Reporting Person's continuous service through each such vesting date.
F2 25% of the shares subject to the option award vested on April 1, 2021, and 6.25% of the shares subject to the option award vested or shall vest in quarterly installments thereafter, subject to the Reporting Person's continuous service through each such vesting date.
F3 25% of the shares subject to the option award vested on February 4, 2022, and 6.25% of the shares subject to the option award vested or shall vest in quarterly installments thereafter, subject to the Reporting Person's continuous service through each such vesting date.
F4 25% of the shares subject to the option award vested on February 16, 2023, and 6.25% of the shares subject to the option award vested or shall vest in quarterly installments thereafter, subject to the Reporting Person's continuous service through each such vesting date.
F5 25% of the shares subject to the option award shall vest on February 16, 2024, and 6.25% of the shares subject to the option award shall vest in quarterly installments thereafter, subject to the Reporting Person's continuous service through each such vesting date.

Remarks:

Exhibit List - Exhibit 24 - Power of Attorney